Kent Emry to Continue as Independent Director Following Planned Leadership Transition ANAHEIM, CA - January 6, 2026 (NEWMEDIAWIRE) - BioCorRx Inc. (OTCID: BICX) (the "Company"), a developer and ...
An ongoing study spotlights the link between calcium deposits in the breast arteries and life-threatening heart risks.
Early recognition of sepsis remains challenging given heterogeneity in presentation. Existing screening tools have not yet ...
Neighborhood-level disadvantages are linked to reduced lower limb strength and mobility in older adults, emphasizing the need ...
Mr. Lucido succeeded Kent Emry, who has served on BioCorRx’s Board of Directors since 2013 and will continue to serve as an independent director, ensuring continuity of leadership and governance.